SCHEMBL132800

SCHEMBL132800

CCOCC(=O)CC(=O)OCC

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.61
MGAM O43451 1/20 0.61
SI P14410 1/20 0.61
MGAM2 Q2M2H8 1/20 0.61
ALDH1A1 P00352 5/20 0.44
TRPA1 O75762 1/20 0.44
CYP1A2 P05177 1/20 0.39
HSD17B10 Q99714 3/20 0.39
LMNA P02545 1/20 0.39
ALOX15 P16050 1/20 0.37
SOAT1 P35610 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TSHR P16473 1/20 0.37
KDM4E B2RXH2 2/20 0.37
FAAH O00519 1/20 0.36
NLRP3 Q96P20 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11385627 0.93 GAA (0.64) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL7892333 0.86 GAA (0.50) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL127353 0.85 FAAH (0.44) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL10892203 0.85 GAA (0.54) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL7639726 0.85 GAA (0.54) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL129596 0.85 GAA (0.54) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL28471811 0.84 ALDH1A1 (0.39) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL130115 0.84 MGAM (0.44) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL155563 0.83 GAA (0.78) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL2601700 0.82 MGAM (0.50) GAAMGAMSIMGAM2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115232008-B Compound, preparation method thereof and application of compound in preparation of fluroxypyr intermediate 山东潍坊润丰化工股份有限公司 2024-05-17 CN disclosed
US-20240010605-A1 COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION OF COMPOUND IN PREPARATION OF BICYCLOPYRONE INTERMEDIATE SHANDONG WEIFANG RAINBOW CHEMICAL CO.,LTD (CN) 2024-01-11 US disclosed
WO-2023237027-A1 COMPOUND, METHOD FOR PREPARING SAME, AND USE THEREOF IN PREPARING BICYCLOPYRONE INTERMEDIATE 山东潍坊润丰化工股份有限公司 2023-12-14 WO disclosed
CN-115232008-A Compound, preparation method thereof and application of compound in preparation of fluroxypyr intermediate 山东潍坊润丰化工股份有限公司 2022-10-25 CN disclosed
CN-114716320-B Compound, preparation method thereof and application of compound in preparation of fluroxypyr intermediate 山东潍坊润丰化工股份有限公司 2022-09-27 CN disclosed
CN-114716320-A Compound, preparation method thereof and application of compound in preparation of fluroxypyr intermediate 山东潍坊润丰化工股份有限公司 2022-07-08 CN disclosed
EP-3759082-B1 PROCESS FOR THE SYNTHESIS OF 6-CHLOROMETHYLURACIL PROCOS SPA (IT) 2022-04-20 EP disclosed
US-11028057-B2 Process for the synthesis of 6-chloromethyluracil PROCOS S.P.A. (IT) 2021-06-08 US disclosed
US-11028057-B2 Process for the synthesis of 6-chloromethyluracil PROCOS S.P.A. (IT) 2021-06-08 US disclosed
EP-3759082-A1 PROCESS FOR THE SYNTHESIS OF 6-CHLOROMETHYLURACIL Procos S.p.A. (IT) 2021-01-06 EP disclosed
WO-2003099275-A1 METHOD FOR THE USE OF PYRANOINDOLE DERIVATIVES TO TREAT INFECTION WITH HEPATITIS C VIRUS WYETH (US) 2003-12-04 WO disclosed
US-4564696-A Process for the production of 4-alkoxyacetoacetic acid esters LONZA LTD. (CH) 1986-01-14 US disclosed
US-4540808-A Process for the preparation of 4-alkoxyacetoacetic acid ester LONZA, LTD. (CH) 1985-09-10 US disclosed
US-4308258-A Pyrimidin-4-yl-phosphorus esters and insecticidal, acaricidal or nematocidal compositions and methods using them SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-12-29 US disclosed
US-4168304-A ARTHROPODICIDES, NEMATOCIDES BAYER AKTIENGESELLSCHAFT (DE) 1979-09-18 US disclosed
US-4126690-A Combating arthropods with N,N-dimethyl-O-[3-(substituted-methyl)-pyrazol-5-yl]-carbamic acid esters BAYER AKTIENGESELLSCHAFT (DE) 1978-11-21 US disclosed
US-4120956-A Combating arthropods with 3-alkoxymethyl- and-alkylthiomethyl-pyrazol(5)yl(thiono)(thiol)-phosphoric(phosphonic) acid esters and ester-amides BAYER AKTIENGESELLSCHAFT (DE) 1978-10-17 US disclosed
US-4020178-A 1,4-Dihydropyridine esters used as coronary dilators and anti-hypertensives BAYER AKTIENGESELLSCHAFT (DT) 1977-04-26 US disclosed
US-3974278-A 1,4-Dihydropyridine esters BAYER AKTIENGESELLSCHAFT (DT) 1976-08-10 US disclosed
US-3971796-A 1,4-Dihydropyridine esters BAYER AKTIENGESELLSCHAFT (DT) 1976-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11028057-B2 Process for the synthesis of 6-chloromethyluracil DHPS, TPMT, MPST GAA 1905/4885MGAM 505/4885SI 514/4885
US-20240010605-A1 COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION OF COMPOUND IN PREPARATION OF BICYCLOPYRONE INTERMEDIATE WEE1, WEE2, CYP4F11 GAA 3744/4885MGAM 3737/4885SI 229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.